Testing infrared scans in ICU patients with ESBL germs
This trial looks at whether using a special infrared testing method in the ICU can help manage patients who carry ESBL germs (a type of bacteria that can be hard to treat). It may help clinicians detect or respond to these bacteria more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older) in the ICU (intensive care unit)
- You currently carry ESBL bacteria (you are an ESBL carrier)
- There are no other listed exclusion reasons for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This study tests whether getting antibiotic resistance test results faster (within 6 hours) helps doctors choose the right antibiotic sooner for ICU patients with bloodstream infections caused by certain bacteria. Faster, accurate treatment may lead to better outcomes.
This study looks at whether certain bacteria that carry ESBL enzymes are spreading between people. To join, you would need lab-confirmed evidence that you carry these bacteria based on routine samples taken during usual care.
This study validates a prediction tool designed to identify which ICU patients are at risk of developing multidrug-resistant gram-negative bacteria (a serious infection resistant to many antibiotics). The tool may help doctors start appropriate treatment earlier and improve patient outcomes.
This study looks at whether patients in the intensive care unit (ICU) carry certain hard-to-treat bacteria (carbapenem-resistant enterobacteriaceae, or CRE) in their gut. By finding out how common this is, doctors can better protect patients from infections.
This trial tests whether measuring drug levels in the blood can help doctors give the right dose of ceftazidime-avibactam (an antibiotic) to patients with hard-to-treat infections in the ICU, potentially improving treatment outcomes and reducing side effects.
Hear when a new Organ Failure, Multiple trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.